| ||||||||||
|
 |
| ||||||||
|
| ||||||||||
|
| ||||||||||
 |
| The Committee on Drugs reviews all aspects of pediatric pharmacology including drug indications, contraindications, absorption rates, routes of administration, dosing, use precautions and mode of action as they apply to children. The Committee also advises the Board of Directors in matters related to drug labeling, safety and efficacy for both prescription and over-the-counter drugs; monitors federal legislation related to the drug approval process; and promotes the need for expanded pediatric drug trials. Current AAP Policies/ Reports Authored by Committee on Drugs News United States Pharmacopeia (USP) Releases Position Statement: "Ten Guiding Principles for Teaching Children and Adolescents about Medicines" According to the USP's "Ten Guiding Principles for Teaching Children and Adolescents About Medicines," children and adolescents have a right to appropriate information and direct communication about medicines. The principles provide guidance to health care professionals, teachers, parents and other caregivers, and are intended to stimulate activities that will help children and adolescents become active participants in the process of using medicines. Working with the USP Pediatrics and Consumer Interest/Health Education Advisory Panels, the USP Ad Hoc Advisory Panel on Children and Medicines was charged with determining how children should learn about medicines and developing model guidelines for what children should know about medicines. The principles are based on recommendations from more than 100 health care professionals, educators and consumer representatives who attended USP's open conference "Children and Medicines: Information Isn't Just for Grownups." They outline children's and adolescents' rights to:
|
|
| ||
|
| ||||||
 | ||||||
| ||||||